Conference Coverage

In utero COVID exposure tied to developmental differences in infants


 

FROM EPA 2022

More research needed

Commenting on the findings, Livio Provenzi, PhD, a psychologist and researcher in developmental psychobiology at the University of Pavia (Italy), noted there is a “great need” to study the direct and indirect effect of the COVID-19 pandemic on parents and their children. “Pregnancy is a period of life which shapes much of our subsequent development, and exposure to adversity in pregnancy can leave long-lasting biological footprints.”

Dr. Provenzi, who was not involved in the study, added in the release that the findings reinforce “evidence of epigenetic alterations in infants born from mothers exposed to pandemic-related stress during pregnancy.

“It shows we need more large-scale, international research to allow us to understand the developmental effects of this health emergency and to deliver better quality of care to parents and infants.”

The study was funded by the Spanish Ministry of Economy and Competitiveness, Instituto de Salud Carlos III through the University of Barcelona multicenter project and the Government of Cantabria. No relevant financial relationships were declared.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Children & COVID: Rise in new cases slows
Journal of Clinical Outcomes Management
Meet the JCOM Author with Dr. Barkoudah: IVIG in Treating Nonventilated COVID-19 Patients With Moderate-to-Severe Hypoxia
Journal of Clinical Outcomes Management
The latest on COVID-19 and the heart in children
Journal of Clinical Outcomes Management
COVID-19 vaccines equally effective in patients on dialysis
Journal of Clinical Outcomes Management
Pfizer asks FDA to authorize COVID vaccine for children younger than 5
Journal of Clinical Outcomes Management
B-cell level may affect COVID booster efficacy in MS
Journal of Clinical Outcomes Management
MS and COVID-19: Conflicting signs on risk but some trends are clearer
Journal of Clinical Outcomes Management
Immunosuppressed rheumatic patients not at high risk of breakthrough COVID-19
Journal of Clinical Outcomes Management
Children and COVID: Cases down, start of vaccinations near
Journal of Clinical Outcomes Management
FDA panel strongly backs protein-based Novavax COVID-19 vaccine
Journal of Clinical Outcomes Management